Molecular Diagnostics: Technologies and Global Markets

May 2022| BIO063E| BCC Publishing
Sample Report

Report Highlights

The global molecular diagnostics market should reach $42.6 billion by 2026 from $17.6 billion in 2021 at a compound annual growth rate (CAGR) of 19.3% for the forecast period of 2021 to 2026.

Report Includes

  • 60 tables
  • An overview of the global market and technologies for molecular diagnostics
  • Estimation of the market size and analyses of global market trends, with data from 2019 to 2021 and projections of compound annual growth rates (CAGRs) through 2026
  • Characterization and quantification of market potential for molecular diagnostic technologies by technology, application and region
  • Information about food and drug administration guidelines and internal standards for DNA diagnostics, and coverage of novel therapeutic products and their approvals
  • Discussion on related issues, government regulations, and reimbursement through insurance, patient confidentiality and other legal ramifications
  • Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size and forecast
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of major players, including Abbott, Becton, Dickinson and Company, General Electric, Siemens Healthcare GmbH and Thermo Fisher Scientific Inc.

Report Scope

This study examines the global market for assays used to detect specific nucleic acid sequences in medical and life science applications. The goal of all DNA-based diagnostic assays is similar, but several different technologies can be employed. BCC Research analyzes each technology in detail, determines major players and current market status, and presents forecasts of growth over the next five years. Scientific challenges and advances, including the latest trends, are emphasized. Government regulations, major collaborations, recent patents and factors affecting the industry from a global perspective are examined. New directions for DNA diagnostic technologies and emerging applications in clinical diagnostics are also examined.

Key molecular diagnostic technologies and products are analyzed to determine present and future market status, and growth is forecast from 2021 to 2026. In-depth discussion of strategic alliances, industry structures, competitive dynamics, patents and market driving forces are also provided.

Frequently Asked Questions (FAQs)

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2020
Forecast period considered 2021-2026
Base year market size $15.1 billion
Market size forecast $42.6 billion
Growth rate CAGR of 19.3% from 2021 to 2026
Units considered $ Millions
Segments covered Technology, Application, Region
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Key Market Drivers
  • High Incidences of Infectious Diseases
  • Increasing Incidences of Chronic Disease
  • Increasing Research and Development Budget
  • Increasing Healthcare Expenditures
Companies studied
  • ABBOTT
  • AGILENT TECHNOLOGIES INC.
  • ALMAC GROUP
  • BECTON, DICKINSON AND CO.
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES, INC.
  • CARDINAL HEALTH
  • DANAHER CORP.
  • ELITECH GROUP
  • GENERAL ELECTRIC
  • HOLOGIC INC.
  • ILLUMINA INC.
  • MYRIAD GENETICS
  • GRIFOLS (NOVARTIS MOLECULAR DIAGNOSTICS)
  • PHILIPS HEALTHCARE
  • QIAGEN N.V.
  • QUEST DIAGNOSTICS
  • ROCHE HOLDING AG (F. HOFFMANN-LA ROCHE LTD.)
  • SIEMENS HEALTHCARE
  • THERMO FISHER SCIENTIFIC INC.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
. Title/Chapter NamePagesPrice Member Price
Full Report: Molecular Diagnostics: Technologies and Global Markets204 $5,500 Free
Chapter- 1: Introduction7Free DownloadFree
Chapter- 2: Summary and Highlights2$250Free
Chapter- 3: Overview5$135Free
Chapter- 4: Impact of the COVID-19 Pandemic3$81Free
Chapter- 5: Market Dynamics12$324Free
Chapter- 6: Market Breakdown by Technology15$404Free
Chapter- 7: Molecular Diagnostics by Application17$458Free
Chapter- 8: Market Breakdown by Region34$917Free
Chapter- 9: Regulations and Finance45$1,213Free
Chapter- 10: Patents19$512Free
Chapter- 11: Competitive Landscape2$54Free
Chapter- 12: Company Profiles43$1,159Free
Published - Oct-2017| Analyst - Jon Evans| Code - BIO063D

Report Highlights

The global molecular diagnostics market was valued at nearly $10.6 billion in 2016. The market is projected to grow at a compound annual growth rate (CAGR) of 14.3% from 2017 through 2022 to reach $12.2 billion by 2017 and $23.8 billion by 2022.

Report Includes 

  • An overview of the global market for molecular diagnostics
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Discussion of related issues, such as government regulations, reimbursement through insurance, patient confidentiality, and other legal ramifications
  • Identification of scientific challenges and advances, including the latest trends in the market
  • A relevant patent analysis
  • Comprehensive company profiles of major players in the field
Published - Jun-2015| Analyst - Jon Evans| Code - BIO063C

Report Highlights

The global molecular diagnostics market was valued at almost $21.7 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 12.5% from 2015 through 2020 to reach nearly $25.2 billion by 2015 and $45.2 billion by 2020.

Report Includes

  • An overview of the global market for molecular diagnostics.
  • Analyses of global market trends, with data from 2012, 2013 and 2014 estimates for 2015, and projections of CAGRs through 2020.
  • Discussion of related issues, such as government regulation, reimbursement through insurance, patient confidentiality, and other legal ramifications.
  • Identification of scientific challenges and advances, including the latest trends in the market.
  • A relevant patent analysis.
  • Comprehensive company profiles of major players in the field of molecular diagnostics.
Published - Mar-2013| Analyst - Jon Evans| Code - BIO063B

Report Highlights

In 2012, the global DNA diagnostics market was valued at $17.3 billion. The total market is projected to reach $20.1 billion in 2013 and nearly $36.5 billion by 2018, increasing at a compound annual growth rate (CAGR) of 12.6% from 2013 through 2018. 

Report Includes

  • An overview of the global market for molecular diagnostics.
  • Analyses of global market trends, with data from 2010 through 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Discussion of related issues, such as government regulation, reimbursement through insurance, patient confidentiality, and other legal ramifications.
  • Identification of scientific challenges and advances, including the latest trends.
  • Comprehensive company profiles and a patent analysis.
Published - Jun-2008| Analyst - Amy Brock| Code - BIO063A

Report Highlights

This Report:

  • By the end of 2008, the global DNA diagnostics market is expected to be valued at $10.6 billion. The total market is projected to grow at a compound annual growth rate (CAGR) of 13.7% to reach $20.1 billion in 2013.
  • PCR-based diagnostic assays should claim the largest share of the market in 2008 and be worth $5.4 billion. The segment will reach $9.5 billion in 2013, for a CAGR of 11.9%.
  • The fastest growing segment of the DNA diagnostics market is the LOAC market, which is expected to reach $890 million in 2008 and $2.1 billion in 2013, for a CAGR of 18.7%.
Molecular Diagnostics: Technologies and Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS